Putting the Patient Back at the Center of Patient-Centered Care

April 11, 2020


From the editor-in-chief of Evidence-Based Oncology™.

Personalized Medicine: The Role of Technology and Diagnostics in Driving Change

March 03, 2020


Rebecca Kaul, MBA, vice president and chief innovation officer at The University of Texas MD Anderson Cancer Center, said the best technology improves the patient experience.

Study Finds Imaging Technique Could Replace Riskier Diagnostic Method for Diabetic Retinopathy

August 30, 2019


Diabetic retinopathy costs the United States $6.2 billion a year. Better screening techniques that can catch neurodegeneration at earlier stages have the potential to cut costs and improve quality of life for patients.

Cancer & Blood Specialists of Louisville Adds New PET/CT Scanner to Improve Cancer Treatment

August 26, 2019


Patients to benefit from new technology that enables physicians to more accurately diagnose and locate cancers.

Biomarker Could Warn of CV Event Risk in Absence of Being Overweight

August 24, 2019


Adding measurement of a key protein during metabolic assessment could help identify those at higher risk of heart attacks and strokes even if they have normal body mass index.

Elevated Troponin in Blood After Exercise Can Indicate Cardiovascular Disease, Study Finds

August 22, 2019


Rising troponin levels after exercise can help identify those at risk of cardiovascular disease or early death; the findings do not mean exercise is harmful.

Unmet Care Targets Suggest Need for Improved Diabetes Care Accessibility

August 18, 2019


Despite advances in therapies for diabetes, those living with the disease are not faring better in reaching treatment targets due to lack of access to care, starting with the ability to be properly diagnosed.

More Data Show Shift to Obesity-Related Cancers in Younger Patients

August 16, 2019


The authors call for more personalized screening protocols to find cancer earlier in younger adults, as well as public health efforts to address obesity.

The Impact of Germline Testing for Hereditary Cancer Postdiagnosis

August 15, 2019


Authors from Facing Our Risk of Cancer Empowered (FORCE), a nonprofit organization focused on hereditary cancer, discuss the importance of genetic testing, guidelines, and coverage considerations.

Genetic Oncology Testing Is Complex, but Coverage and Reimbursement Don't Have to Be

August 15, 2019


The chief clinical officer of health plans and policy for Quest Diagnostics discusses how payers can assess the value of genetic testing in oncology.